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Iron deficiency anemia and anemia of chronic disease in
geriatric hospitalized patients: How frequent are
comorbidities as an additional explanation for the anemia?
Etienne Joosten and Pieter Lioen
Department of Internal Medicine, Division of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium
Aim: Anemia is an important clinical problem in older patients. The aim of the present study was to investigate
whether comorbidities as an additional explanation for the severity of the anemia are frequent, and might help to
explain the anemia severity in older patients with iron deficiency anemia (IDA) and the anemia of chronic disease
(ACD).
Methods: In the present prospective study, 191 consecutive hospitalized older patients with IDA and the ACD were
investigated. A peripheral blood count, C-reactive protein, standard iron parameters, serum vitamin B12 and folate,
and renal and thyroidal function tests were analyzed. The attending geriatrician was responsible for the medical
diagnosis and follow up.
Results: A total of 56 patients with IDA and 135 with the ACD were investigated. Just 24 patients with IDA had
normal serum folate, vitamin B12 and thyroid-stimulating hormone levels without laboratory evidence of inflammation
or chronic renal failure, but one of these patients was diagnosed with hemolytic anemia. Hence, 23 patients (41%)
were diagnosed with “IDA only”. “ACD only” was diagnosed in 104 patients (77%), and 22 patients (16%) with ACD
had chronic renal failure. A myelodysplastic syndrome was found in two patients.
Conclusions: Additional etiologies are often diagnosed in anemic older patients, but it remains unknown to what
extent these diseases might influence the pathogenesis of the anemia. Individual and clinical judgment remain crucial
to evaluating and treating older anemic patients. Geriatr Gerontol Int 2014; ••: ••–••.
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Introduction
Anemia is an important clinical problem in elderly
patients, and might contribute to an increased rate of
morbidity and mortality. The anemia of chronic disease
(ACD), also called anemia of inflammation, and iron
deficiency anemia (IDA) are the two most prevalent
causes of anemia in hospitalized older patients.1,2 ACD
develops in patients with an acute or chronic infection,
autoimmune disease or malignancy. IDA most com-
monly results from chronic gastrointestinal blood loss.
There are no standard diagnostic criteria to classify IDA
and ACD, and their diagnosis is often a clinical chal-
lenge. Serum ferritin is the most commonly used labo-
ratory parameter to differentiate between IDA and ACD,
but it is also an acute phase reactant and its level
increases with age. The usefulness of additional analy-
ses, such as reticulocyte hemoglobin equivalent, serum
hepcidin, serum transferrin receptor and serum trans-
ferrin receptor/log serum ferritin, is unclear and some of
these tests are not routinely available.3–5 In specific
organ-related diseases, at least two causes contributing
to the anemia were found in 63.8% anemic patients
with chronic heart failure,6 more than 50% in patients
with diabetes,7 and 63% of the anemic patients with an
inflammatory bowel disease had both ACD and IDA.8
However, it is more difficult to assess the impact of two
classical hematological diseases on the hemoglobin level
in the same anemic patient. Recent studies have shown
that the underlying cause of the anemia is multifactorial
in a substantial number of community-dwelling, as well
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as in hospitalized, older anemic patients, but more
detailed research is lacking.2,9,10 Aim of the present study
was to investigate the prevalence, and whether addi-
tional diseases might influence the hemoglobin level in
older hospitalized patients with IDA and ACD using
generally accepted laboratory and clinical criteria.
Methods
In a prospective study, we investigated 191 consecutive
older patients aged 70 years and older with a diagnosis
of IDA and ACD according to specific diagnostic criteria
and admitted to the acute geriatric ward of a tertiary care
hospital. Some of these patients participated in a previ-
ously published study on the significance of the reticu-
locyte hemoglobin equivalent for the diagnosis of IDA.5
A complete blood count including mean corpuscular
volume, serum ferritin, vitamin B12, folate, iron, trans-
ferrin, transferrin saturation, C-reactive protein (CRP),
thyroid-stimulating hormone (TSH), creatinine and the
estimated glomerular filtration rate (eGFR) were ana-
lyzed according to routine laboratory methods.5 Anemia
was defined as a serum hemoglobin <13 g/dL for men
and <12 g/dL for women. In our laboratory, the upper
limit of normality for serum CRP is 5 mg/L and a level
>5 mg/L was therefore chosen as a marker for inflam-
mation. IDA was defined as a serum ferritin level
<50 μg/L and a transferrin saturation ≤20%, irrespective
of the serum CRP level.11,12 ACD was considered present
if the patient had all of the following criteria: a serum
ferritin level ≥50 μg/L, serum CRP level >5 mg/L, a
transferrin saturation ≤20% and the presence of a clini-
cal diagnosis of an acute or chronic infection, autoim-
mune disease or malignancy.5,11,13 Vitamin B12 deficiency
was diagnosed if the serum vitamin B12 concentration
was less than 200 ng/L, and folate deficiency if the
serum folate level was less than 4 μg/L. An abnormal
TSH level was defined if the serum level was less than
0.1 or higher than 10 mIU/L, respectively.11 Patients
with an eGFR ≤30 mL/min/1.73 m2 were classified as
having the anemia of chronic kidney disease (CKD). All
patients were examined by their treating geriatrician,
who was responsible for the medical follow up, techni-
cal investigations and the interpretation of the medical
data. Patients treated with red blood cell transfusion or
taking iron during the past 2 months were excluded.
The present study protocol was approved by the ethical
committee of University Hospitals Leuven, Leuven,
Belgium, and patients were included after oral
consent.
Statistical analyses were carried out with SPSS
Statistics version 20. The Kolmogorov–Smirnoff test
was used to investigate the normal distribution of the
parameters. Comparison between two groups was
carried out by the Student’s t-test or the Mann–Whitney
U-test, depending on the parametric or non-parametric
distribution of the data.
Results
The clinical and laboratory characteristics of the total
study population are shown in Table 1.
Table 1 Characteristics of 56 patients with iron deficiency anemia and 135
patients with anemia of chronic disease
IDA ACD P
(n = 56) (n = 135)
Age (years) 84.2 (5.7) 84.3 (5.4) 0.91
Female, n (%) 34 (61) 73 (54) 0.4
Hemoglobin (g/dL) 9.5 (1.8) 10.6 (1.3) <0.001
MCV (fL) 81 (9.5) 90.5 (6.7) <0.001
CRP (mg/L) 13.3 (16) 96.5 (88) <0.001
Serum iron (μg/dL) 27.4 (15.5) 27.8 (13.6) 0.69
Serum transferring (g/L) 3.2 (0.57) 1.9 (0.42) <0.001
Saturation index (%) 6.4 (4.0) 10.5 (4.5) <0.001
Ferritin (μg/L) 22.1 (13) 316 (256) <0.001
Serum vitamin B12 (ng/L) 487 (312) 597 (359) 0.02
Serum folate (μg/L) 11.4 (5) 11.3 (4.9) 0.87
TSH (mIU/L) 1.66 (1.6) 1.42 (1.1) 0.39
eGFR (mL/min/1.73 m2) 55.8 (18) 54.2 (23) 0.57
Values are presented as mean (standard deviation) except as otherwise indicated.
ACD, anemia of chronic disease; CRP, C-reactive protein; eGFR, estimated
glomerular filtration rate; IDA, iron deficiency anemia; MCV, mean corpuscular
volume; TSH, thyroid-stimulating hormone.
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IDA
IDA was diagnosed in 56 patients (34 women). Just 24
of these patients fulfilled all of the following criteria: a
CRP ≤ 5 mg/L, eGFR >30 mL/min/1.73 m2, and normal
serum vitamin B12, folate and TSH levels. One of these
patients was diagnosed with a hemolytic anemia as a
result of a mechanical aortic valve repair, hence 23
patients (41%) were diagnosed as having “IDA only”
(Table 2). There was also one patient each with a
CRP ≤ 5 mg/L and vitamin B12 deficiency or CKD. A
total of 30 patients had a CRP > 5 mg/L, of whom two
were diagnosed with CKD, three with thyroid dysfunc-
tion, one patient with CKD and thyroid dysfunction,
one patient with a myelodysplastic syndrome (MDS)
and 23 without any of the aforementioned
comorbidities (Table 2). It is noteworthy that in the
latter 23 patients, the diagnosis of a colorectal cancer
and an acute infectious condition, commonly found in
patients with ACD, was made in three and 11 patients,
respectively. The mean hemoglobin level in the 23
patients with “IDA only” was 8.9 ± 1.9 g/dL, as com-
pared with 9.8 ± 1.6 g/dL in the 33 other IDA patients
(P = 0.06). A total of 31 of the IDA patients had a serum
ferritin level <20 μg/L, of whom 14 had a CRP level
>5 mg/L.
The results of the upper and lower gastrointestinal
endoscopic investigation in the total group of IDA
patients were as follows: a benign gastrointestinal lesion
(erosions and ulcers of the upper gastrointestinal tract,
arteriovenous malformation, hemorrhoids) was found
in 18 patients, a colorectal cancer in seven and one or
more dysplastic colorectal polyps in another three
patients. No cause for the blood loss was found in the
other 28 patients (50%). Of the latter patients, 11
refused an esophagogastroduodenoscopy and a colo-
noscopy or were in a poor clinical condition, the result
of an esophagogastroduodenoscopy and colonoscopy
was negative in 11, and six other patients underwent an
esophagogastroduodenoscopy without a specific lesion,
but no colonoscopy.
ACD
ACD was diagnosed in 135 patients (73 women). All
patients had a serum CRP level >5 mg/L, of whom 127
(94%) had a CRP level >10 mg/L. A total of 21 patients
(16%) had an eGFR ≤ 30 mL/min/1.73 m2, a TSH level
<0.1 mIU/L or >10 mIU/L was found in eight patients
(6.6%), and one patient had CKD and thyroid dysfunc-
tion (Table 2). A total of 105 ACD patients (78%) had
both an eGFR >30 mL/min/1.73 m2 and a TSH level >0.l
and <10 mIU/L. One of these patients was diagnosed
with a MDS during hospitalization, hence 104 patients
were classified as “ACD only” (Table 2). The mean
hemoglobin level in the latter 104 patients was
10.6 ± 1.4 g/dL and 10.6 ± 1.2 g/dL in the other 31
patients (P = 0.6). All ACD patients had normal serum
vitamin B12 and folate levels. The prevalences of the
main clinical diagnosis of an acute or chronic infection,
autoimmune disease or malignancy as part of the diag-
nostic criteria for ACD were as follows: an acute infec-
tious process, mainly of the respiratory tract (n = 50),
urinary tract (n = 22) and gastrointestinal tract (n = 13)
was found in 96 patients (71%); cancer in 17 patients
(12.3%; prostate cancer 6, colon carcinoma 3, lung car-
cinoma 2, other cancers 6) and a chronic infectious
process or autoimmune inflammatory disease (mainly
gout, rheumatoid arthritis, giant cell arteritis/
polymyalgia, chronic pressure ulcer, spondylodiscitis)
was detected in 22 patients (16%).
Discussion
In the present study, we investigated to what extent
additional diseases associated with anemia are of clinical
significance in patients with IDA and ACD. Less than
half of the patients with IDA had “IDA only,” defined
as a serum ferritin <50 μg/L without inflammation,
chronic kidney failure, vitamin B12 or folate deficiency,
thyroid dysfunction, or any other known cause for the
anemia. The mean hemoglobin level was not statistically
different between patients with “IDA only” and IDA
Table 2 comorbidities in patients with iron
deficiency anemia and anemia of chronic disease
Comorbidities n n with
CRP ≤ 5 mg/L
IDA (n = 56)
IDA only 23 23
IDA and hemolytic anemia 1 1
IDA and vitamin B12 deficiency 1 1
IDA and CKD 3 1
IDA and thyroid dysfunction 3 0
IDA and CKD and thyroid
dysfunction
1 0
IDA and myelodysplastic
syndrome
1 0
IDA and other comorbidities 23 0
ACD (n = 135)
ACD only 104 0
ACD and myelodysplastic
syndrome
1 0
ACD and CKD 21 0
ACD and thyroid dysfunction 8 0
ACD and CKD and thyroid
dysfunction
1 0
ACD, anemia of chronic disease; CRP, C-reactive protein;
CKD, chronic kidney disease; IDA, iron deficiency anemia.
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with additional conditions, as well as in patients with
“ACD only” and ACD with additional conditions. Only
one patient with vitamin B12 deficiency and no cases
with folate deficiency were found. Besides the clinical
diagnosis of an inflammatory disease, which was obliga-
tory for the diagnosis of ACD, 16.2% and 6.7% of the
ACD patients had chronic renal failure and thyroid dys-
function, respectively. In 77% of the patients with ACD,
no CKD, vitamin B12 or folate deficiency, thyroid dys-
function, or any other additional explanation for the
anemia could be diagnosed. Hence, these patients were
diagnosed as “ACD only.” In most studies, a single and
predominant cause for the anemia is identified. This is
based on clinical arguments or a predefined sequential
approach in order to give priority to treatable condi-
tions.9,11,14 From a clinical point of view, this means that
what are commonly called “nutritional anemia” (iron,
vitamin B12 and folate deficiency) and anemia of chronic
disease are mostly at the top of the list.9,11 As a conse-
quence, the diagnosis of anemia as a result of other
etiologies, such as CKD, thyroid dysfunction or attrib-
uted to specific hematological diseases (e.g. MDS,
hemolytic anemia, multiple myeloma etc.) are mostly
dictated on specific clinical and laboratory grounds, or
diagnosed after exclusion of other diseases.11
Only a few studies have focused in general on the
multifactorial etiology of anemia.2,9–11,15 In a large popu-
lation of ambulatory older subjects, 5.4% of the subjects
had a combination of vitamin B12, folate or iron defi-
ciency, and an additional 4.3% had renal insufficiency
and ACD.9 In a cohort of 696 ambulatory and hospital-
ized patients, 43% had at least two causes of anemia.15
Petrosyan et al. diagnosed anemia as multifactorial in
46.3% of a cohort of 95 hospitalized older patients.2 In
the present study, the anemia was multifactorial in 33 of
the 56 patients with IDA and in 31 of the 135 patients
with ACD. It is rather a “semantic” discussion whether
the anemia in patients with a low serum ferritin level in
combination with an increased CRP level should be
labeled as pure IDA, ACD or a combination of the two.
Some physicians will investigate these patients for
chronic gastrointestinal blood loss and will start iron
supplementation. Another option could be to start a
gastrointestinal exploration once the underlying inflam-
matory disease has been resolved, but this delay could
lead to an important loss of time, especially in the case
of specific gastrointestinal lesions, such as a colonic
tumor or gastric ulcer. However, it is possible that this
multifactorial origin of the anemia, for example, in
patients with IDA, could be the trigger for the non-
responsiveness to iron supplements, at least in some of
these patients. In virtually all studies, the main subject
of investigation in patients with IDA is the gastrointes-
tinal tract in order to find a cause for the chronic blood
loss. A potential gastrointestinal lesion as a source of the
bleeding was found in 50% of our patients, and this is in
accordance with other studies.16,17 A similar “semantic”
problem occurs in patients with ACD in combination
with, for example, CKD. High levels of inflammatory
markers, the presence of an inflammatory clinical con-
dition in many cases, inappropriately low serum eryth-
ropoietin levels relative to the degree of anemia, and
elevated hepcidin levels overlap between ACD and the
anemia of CKD.4,18–20 It is still a matter of debate whether
CKD should be considered as a separate cause or as part
of the ACD spectrum.11,13,16,19–21 In the present study,
more patients were diagnosed with ACD than IDA. This
is in agreement with the results of Guralnik et al.9 and
Petrosyan et al.,2 who used only laboratory criteria to
define ACD. In other studies, ACD was diagnosed after
the elimination of other causes or in the setting of a
clinically active inflammatory disease without laboratory
criteria, and a much lower prevalence for ACD as com-
pared with IDA was shown.11,14 A possible explanation
for these disparities might be the differences in meth-
odologies used to define the different causes of anemia
and this might explain, at least partly, the wide variation
of the prevalence of unexplained anemia in different
studies.2,9,11,14
The present study had several limitations. We studied
only patients with IDA and ACD according to specific
diagnostic criteria, and the majority of the latter group
had an acute infection. Our study was a clinical and not
a physiopathological study, hence we could no show to
what extent the different diseases are responsible for the
anemia in each patient. The lack of generally accepted
and well standardized criteria for IDA and ACD results
in varying prevalences of these types of anemia in dif-
ferent studies, and the high prevalence of concomitant
diseases complicates the interpretation of the traditional
laboratory analyses. Unfortunately, serum methyl-
malonic acid and homocysteine analysis neither a thera-
peutical trial with vitamin B12, folate, iron or a corrective
treatment for the thyroid disease were carried out to
exclude or confirm the specific diagnosis of vitamin
B12, folate and iron deficiency or a thyroid dysfunction,
but patients were treated on an individual basis by
their attending geriatrician. We studied a group of
older hospitalized patients with a geriatric profile
(multimorbidity, atypical presentation of clinical symp-
toms, polypharmacy, frailty, cognitive impairment etc.).
Hence, the present results cannot be generalized to
other ambulatory or hospitalized elderly patients. A
bone marrow investigation is often deferred or refused
by patients, and was only carried out as proposed by the
responsible geriatrician. A bone marrow aspirate is not
always diagnostic for iron deficiency.22 However, it is
useful in patients with unexplained anemia and suspi-
cious laboratory abnormalities, such as unexplained
macrocytosis, neutropenia, thrombocytopenia or pan-
cytopenia, in order to diagnose specific hematological
diseases, such as MDS or other hematological
E Joosten and P Lioen
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malignancies. MDS was diagnosed in two patients, and
this is probably an underestimation as compared with
our previously published report.1 However, anemia was
already attributed to IDA or ACD, and MDS remains a
relatively rare disease, even in elderly patients.1,11 Other
laboratory parameters, such as the serum transferrin
receptor analysis or hepcidin, are valuable tests for the
evaluation of the iron status and the differential diag-
nosis between IDA and ACD, but these tests are not
routinely available or not well standardized.3,4,12,23
In conclusion, the diagnosis of IDA and ACD is not
straightforward in older patients. Additional diseases
that could modify the hemoglobin levels are often diag-
nosed in these patients. An inflammatory disease is a
frequent comorbidity in patients with IDA, as is chronic
renal failure in patients with ACD, but the presence
of comorbidities did not influence the severity of the
anemia. Individual and clinical judgment favoring
the predominant and potentially treatable cause for
the anemia remain crucial to evaluating and treating
older anemic patients until more accurate criteria
become available. Further research is required to deter-
mine which diagnostic and therapeutic options are
optimal for patients with a multifactorial anemia.
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